Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Successful prevention of sudden death by ICD has implications for heart failure

Successful prevention of sudden death by ICD has implications for heart failure

June 13, 2006

Researchers believe a device that treats electrical malfunctions in the heart is so effective at preventing sudden death that very ill patients are living long enough to develop heart failure. The results direct attention to an urgent need in cardiology to better address, in tandem, risk for sudden cardiac death and heart failure common to many patients, according to a study published today in Circulation: Journal of the American Heart Association. The study sets the stage for a related clinical trial, just underway, that seeks to prove that new techniques can treat electrical malfunctions while reducing heart failure by 25 percent.

Implantable cardioverter defibrillators (ICDs) are devices designed to correct arrhythmias, electrical malfunctions that throw the heart out of rhythm and cause many of the 330,000 sudden cardiac deaths each year in the United States. Most fatal arrhythmias in the aging are caused by scar tissue left behind by heart attacks that interferes with the heart's electrical system. The connection has caused some to confuse sudden cardiac death with heart attack, which is brought when a blocked artery kills heart muscle. Many also confuse heart attack with heart failure, where heart becomes too insufficient to pump enough blood to meet the body's needs.




ICDs have been used more widely since studies found that the devices could reduce sudden death by up to 54 percent in those patients most at risk for arrhythmia: heart attack survivors. Led out of the University of Rochester Medical Center, the 2002 MADIT II study (Multicenter Automatic Defibrillator Implantation Trial II) in particular changed medical guidelines nationwide and made a hundred thousand heart attack survivors eligible for ICD therapy. The newly published study, from the MADIT II data, found that those same people who live longer are at increased risk of developing heart failure later on.

"Our results show that cardiologists and ICD patients nationwide because need to pay much greater attention to heart failure," said Ilan Goldenberg, M.D., research assistant professor at the University of Rochester Medical Center and lead author of the new re-analysis of MADIT-II. "Otherwise, effective treatment for arrhythmia may transform the risk of sudden death into a subsequent heart failure risk. If we could ramp up heart failure prevention along with implantation of ICDs, this will improve the quality of life in patients who live longer."

The original MADIT-II trial included 1,232 patients with an ejection fraction of 30 percent or less who had a heart attack at least a month before enrollment. Ejection fraction is a measure of the heart's pumping strength, and is reduced in patients in some stage of heart failure. With a healthy ejection fraction being about 60, the hearts of patients in MADIT-II were pumping blood with about half the force of healthy hearts.

In the newly published sub-analysis, patients who had ICDs implanted were 39 percent more likely to have a first hospitalization for heart failure than those who received only medical therapy after a heart attack, and 58 percent more likely to be hospitalized for recurrent heart failure during an average 20-month follow up.

The Next Step

A preventive strategy to reduce the risk of heart failure in ICD patients is currently being evaluated in yet another follow-up study to MADIT-II: The Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT). MADIT-CRT is designed to determine if the combination of ICD and resynchronization therapies can reduce the risk of mortality and heart failure events by approximately 25 percent.

A standard ICD includes one lead, a wire inserted into the heart that stands ready to shock the heart back into normal rhythm should an arrhythmia occur. Patients with both risk of arrhythmia and heart failure, however, have a second problem, a timing delay in the pumping signal as it passes between the right and left parts of the heart. The delay can accelerate heart failure and a single-lead ICD cannot address the problem. A new generation of ICDs designed with two leads has the potential to both stop arrhythmias and re-synchronize the heartbeat when necessary, reducing heart failure, according to theory and preliminary studies.

"Now that we are have had some success in preventing sudden cardiac death, it is imperative that we do more as a nation to address heart failure," said Arthur J. Moss, M.D., professor of Medicine in the Division of Cardiology and Director of the Heart Research Follow-up Program. "Future studies will need to address the best combination of treatment to stop both sudden cardiac death and heart failure, to improve the quantity and quality of life."

University of Rochester Medical Center



Related Heart Failure Current Events and Heart Failure News Articles Heart Failure Current Events and Heart Failure News RSS Heart Failure Current Events and Heart Failure News RSS
University of Minnesota invention will help speed development of drug treatments for heart failure
Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure.

New tool for helping pediatric heart surgery
A team of researchers at the University of California, San Diego and Stanford University has developed a way to simulate blood flow on the computer to optimize surgical designs.

Carvedilol shown to have unique characteristics among beta blockers
In a new study, researchers report that a class of heart medications called beta-blockers can have a helpful, or harmful, effect on the heart, depending on their molecular activity.

High Blood Pressure Easy to Miss in Children with Kidney Disease
Spot blood pressure readings in children with chronic kidney disease often fail to detect hypertension - even during doctor's office visits - increasing a child's risk for serious heart problems, according to research from Johns Hopkins Children's Center and other institutions. A report of the findings appears online in the Journal of American Society of Nephrology.

Inhibition of GRK2 is protective against acute cardiac stress injuries
Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion.

Young athletes need dual screening tests for heart defects, study suggests
To best detect early signs of life-threatening heart defects in young athletes, screening programs should include both popular diagnostic tests, not just one of them, according to new research from heart experts at Johns Hopkins.

Protein changes in heart strengthen link between Alzheimer's disease and chronic heart failure
A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States.

Elevated biomarkers lead to diminished quality of life in heart attack patients post-discharge
Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study.

Tiny particles can deliver antioxidant enzyme to injured heart cells
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.

New study links vitamin D deficiency to cardiovascular disease and death
While mothers have known that feeding their kids milk builds strong bones, a new study by researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City suggests that Vitamin D contributes to a strong and healthy heart as well - and that inadequate levels of the vitamin may significantly increase a person's risk of stroke, heart disease, and death, even among people who've never had heart disease.
More Heart Failure Current Events and Heart Failure News Articles
Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure

Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure
by Marc Silver (Author)

Up-to-date information on available and forthcoming medical and surgical treatments.

How attitude and emotion affect heart failure--and what you can do to stay positive.

Tips for adopting a heart-healthy diet and lifestyle.

Ways to forge a positive working relationship with your doctor or cardiologist.



The Cleveland Clinic Guide to Heart Failure (Cleveland Clinic Guides)

The Cleveland Clinic Guide to Heart Failure (Cleveland Clinic Guides)
by Randall Starling (Author)

Expert medical advice from the #1 heart center in America for 14 years in a row

 

For the 5 million people with heart failure, there’s new reason for hope: recent medical advances have revolutionized how this condition is managed.

 

In The Cleveland Clinic Guide to Heart Failure, Dr. Randall Starling, one of the foremost authorities on heart health, provides authoritative advice to help people survive heart failure and enjoy a good quality of life. This comprehensive resource gives readers the cutting-edge medical guidance Dr. Starling offers his patients, including:

 

* Insight into what causes heart failure

* The latest breakthrough studies – and what those discoveries mean for the future

of this disease

* Reliable guidance on diagnostic tests and treatment...

Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management (HEART FAILURE: PATHOPHYSIOLOGY, MOLEC BIOL & CLIN MGT)

Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management (HEART FAILURE: PATHOPHYSIOLOGY, MOLEC BIOL & CLIN MGT)
by Arnold M Katz (Author), Marvin A Konstam (Author)

This Second Edition of Dr. Katz's highly acclaimed text has been thoroughly revised to incorporate the latest advances in the study and treatment of heart failure. The book explains the pathophysiology, molecular mechanisms, clinical manifestations, and therapy of heart failure in an integrated, reader-friendly manner that is accessible to both clinicians and basic scientists. More than 100 illustrations, most created for this book by the authors, complement the text. This edition has been completely reorganized. Chapters describe the hemodynamic basis for the clinical manifestations of heart failure; the neurohumoral responses in heart failure and key signaling pathways that mediate functional responses; the proliferative responses in failing hearts; the cellular and molecular...

Manual of Heart Failure Management

Manual of Heart Failure Management
by John. D Bisognano (Editor), Marc. L. Baker (Editor), Mary Beth Earley (Editor)

Heart failure is an increasingly common occurance in the patient population despite better treatment and management options available to clinicians. The focus is now increasingly turning towards prevention to reduce the rising incidence in addition to more efficacious treatment regimens.

With emphasis on practical knowledge and easy reference, this title is designed to present the relevant diagnostic, management and treatment information in an easily digested and evidence-based algorithm format. With use of illustrations, readers will be able to rely on this text as a basic primer when studying patients with this complex and multifaceted set of diseases.



ABC of Heart Failure (ABC Series)

ABC of Heart Failure (ABC Series)
by Russell C. Davis (Author), Michael K. Davies (Author), Gregory Y. H. Lip (Author)

This new edition of the ABC of Heart Failure provides coherent and concise information relating to the epidemiology, pathophysiology and clinical features, aiding the diagnosis and treatment of this life threatening condition.

Fully updated to cover all the latest advances, the ABC of Heart Failure is an invaluable reference for general practitioners, hospital doctors, nurses and other healthcare professionals involved in the treatment and prevention of heart failure.

Heart Failure

Heart Failure

Heart failure, also called congestive heart failure, is a condition in which the heart cannot pump enough oxygenated blood to meet the needs of the body?s other organs. The heart keeps pumping, but not as efficiently as a healthy heart. Usually, the loss in the heart?s pumping action is a symptom of an underlying heart problem. Heart failure affects nearly 5 million US adults. It is on the rise with an estimated 400,000 to 700,000 new cases each year. This talk will focus on the causes, symptoms, diagnosis and treatments available for heart failure, including current research findings from Stanford.

FlameEz-Heart, 60 Capsules/Bottle

FlameEz-Heart, 60 Capsules/Bottle
by FlameEz

Conditions that damage the heart muscle or make it work too hard can cause heart failure. Over time, the heart weakens and certain inflammatory substances may be released into the blood, which have a toxic effect on the heart and cause heart failure to worsen. The most common causes of heart failure are coronary artery disease, high blood pressure, and diabetes, all of which are associated with chronic inflammation. Inflammatory cytokines suppress heart contractility, initiate hypertrophy and promote cell death or fibrosis. Results from a recent study land additional support that obesity causes prolonged inflammation of heart tissue that in turn boosts heart failure risk. New studies also suggest that modulation of inflammatory and immune responses may offer some hope to improve heart...

  Holy Heart Failure
by Holy Heart Failure



  LifeMasters {Heart Failure Treatment: Getting Started, Understanding Heart Failure Medications}
Also With: LifeMasters (Producer)

*** HEART FAILURE TREATMENT: GETTING STARTED - This video shows you how taking an active role in treatment can help you improve your quality of life and stay out of the hospital. It outlines a basic treatment plan and ecnourages you to work with your LifeMasters nurse to make the goals of treatment personal and realistic. UNDERSTANDING HEART FAILURE MEDICATIONS - Using patient testimonials, this program shows you how the medications available today make heart failure a manageable condition. It covers the main classifications of drugs, their side effects, and possible dosage adjustments. Practical tips to help you organize multiple medications are included. ***

Congestive Heart Failure Awareness Ribbon Mouse Pad

Congestive Heart Failure Awareness Ribbon Mouse Pad
by MyHeritageWear.com

The Congestive Heart Failure Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Congestive Heart Failure Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Congestive Heart Failure Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness!

© 2009 BrightSurf.com